Analysis of Vaginal Microbiota Variations in the Third Trimester of Pregnancy and Their Correlation with Preterm Birth: A Case-Control Study.

This study conducted a detailed analysis of the vaginal microbiota in pregnant women to explore its correlation with preterm birth (PTB) outcomes. The primary objective was to identify microbial variations associated with increased PTB risk. Secondary objectives included investigating how changes in microbial composition relate to the local immune environment and PTB. Utilizing a retrospective case-control design, the study involved pregnant women with liveborn infants between 2019 and 2023. In total, 89 women who delivered preterm and 106 term deliveries were included. Data collection focused on third-trimester vaginal cultures. Statistically significant differences were observed between the preterm and full-term groups in several areas. The median white blood cell count (10.2 × 10/mm vs. 7.6 × 10/mm, = 0.009) and neutrophil count (7.2 × 10/mm vs. 5.1 × 10/mm, < 0.001) were higher in the preterm group. Vaginal pH was also elevated in preterm births (5.6 vs. 4.4, < 0.001), with a higher prevalence of bacterial vaginosis (29.2% vs. 12.3%, = 0.001) as indicated by the Nugent Score. The study noted a significant association of PTB with the presence of spp. (OR = 1.84, = 0.018), (OR = 2.29, = 0.003), (OR = 1.97, = 0.007), and (OR = 2.43, = 0.001). Conversely, a reduction in spp. correlated with a decreased PTB risk (OR = 0.46, = 0.001). The study provides compelling evidence that specific vaginal microbiota components, particularly certain pathogenic bacteria and an altered Lactobacillus profile, are significantly associated with PTB risk. These findings highlight the potential of targeting microbial factors in strategies aimed at reducing PTB rates. Further research is necessary to fully understand the complex interplay between microbial dynamics, host immunity, and PTB outcomes.